Professor Mark Febbraio is a Senior Principal Research Fellow of the NHMRC, is the Head of the Cellular and Molecular Metabolism Laboratory and Head of the Division of Diabetes & Metabolism at The Garvan Institute of Medical Research in Sydney, Australia. He is also the Chief Scientific Officer of N-Gene Research Laboratories Inc., a USA based Biotechnology Company. His research is focussed on understanding cellular and molecular mechanisms associated obesity and type 2 diabetes and his aim is to develop novel drugs to treat metabolic disease. He has authored over 200 peer reviewed papers in leading journals. He has won prizes at international, national and institutional levels including the A K McIntyre Prize for significant contributions to Australian Physiological Science (1999), the Colin I Johnson Lectureship by the High Blood Pressure Research Council of Australia (2006) the ESA/ADS Joint Plenary Lecture (2009), the Sandford Skinner Oration (2011) and Eureka Scientific Prize Finalist (2013). He is on the Editorial Board of Diabetes, The American Journal of Physiology Endocrinology & Metabolism, and the Journal of Applied Physiology. Professor Febbraio is also dedicated to health and fitness and continues to complete in running races and multi-sport events.
« Go Back